Visiomed Group SA (FR:ALKLH) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Klea Holding’s Board of Directors has unanimously rejected a consortium’s offer to purchase all outstanding shares at €0.30 per share, deeming it undervalued compared to an independent analyst’s valuation of €0.45 per share. The decision was based on the consortium’s inability to meet financial and strategic criteria, including a failure to provide binding proof of funding and a lack of support from major shareholders. Klea Holding’s recent growth and profitability improvements underscore the board’s confidence in the company’s higher valuation potential.
For further insights into FR:ALKLH stock, check out TipRanks’ Stock Analysis page.
